Asthma inhaler switch in 2024 could leave some patients scrambling
A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives.
Dec 29, 2023
0
0
A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives.
Dec 29, 2023
0
0
A French appeals court on Wednesday ordered pharmaceutical firm Servier to pay more than $460 million in damages over a scandal involving a diabetes drug linked to hundreds of deaths.
Dec 20, 2023
0
0
The use of prior authorizations by insurance companies for certain oral cancer drugs can lead to significant delays in patients' obtaining the medication and make it more likely that some would discontinue the drug, according ...
Dec 13, 2023
0
0
A new generation of obesity drugs often delivers dramatic weight loss, but many patients wonder what happens when they stop treatment.
Dec 11, 2023
1
27
Among patients with metastatic breast cancer, those who took part in a nine-month structured exercise program reported less fatigue and an improved quality of life compared to those who did not undergo the exercise program, ...
Dec 7, 2023
0
0
Seeking the GOP nomination for president, Florida Gov. Ron DeSantis said in an interview that aired Sunday on NBC's "Meet the Press" that he plans on unveiling a health care proposal next year that would "supersede" Obamacare.
Dec 4, 2023
0
1
Health care has historically been slow to adopt new technologies that involve wholesale changes to the nature of the work. Witness the slow and checkered roll-out of electronic health records and the utter failure of prior ...
Dec 1, 2023
0
1
After years of debilitating bouts of fatigue, Beth VanOrden finally thought she had an answer to her problems in 2016 when she was diagnosed with Hashimoto's disease, an autoimmune disorder.
Nov 29, 2023
0
0
In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%.
Nov 13, 2023
0
0
The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly's highly anticipated weight loss drug Zepbound, the latest entrant in a field of powerful—and lucrative—new obesity medicines.
Nov 8, 2023
0
0